Cost Effectiveness Analysis of Sorafenib Versus Best Supportive Care in Patients with Advanced Hepatocellular Carcinoma from Health Care System Perspective in Egypt
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.235
https://www.valueinhealthjournal.com/article/S1098-3015(17)30569-7/fulltext
Title :
Cost Effectiveness Analysis of Sorafenib Versus Best Supportive Care in Patients with Advanced Hepatocellular Carcinoma from Health Care System Perspective in Egypt
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30569-7&doi=10.1016/j.jval.2017.08.235
First page :
A439
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
213